参考文献/References:
[1] Liu Q,Xiao S,Xia Y.TWEAK/Fn14 activation participates in skin inflammation[J].Mediators Inflamm,2017,2017:1-12.
[2] Sidler D,Wu P,Herro R,et al.TWEAK mediates inflammation in experimental atopic dermatitis and psoriasis[J].Nat Commun,2017,8:15395.
[3] Cheng H,Xu M,Liu X,et al.TWEAK/Fn14 activation induces keratinocyte proliferation under psoriatic inflammation[J].Exp Dermatol,2016,25(1):32-37.
[4] Sabour AS,Dessirier V,de Araujo E,et al.TWEAK affects keratinocyte G2/M growth arrest and induces apoptosis through the translocation of the AIF protein to the nucleus[J].PLoS One,2012,7(3):e33609.
[5] Peng L,Li Q,Wang H,et al.Fn14 deficiency ameliorates psoriasis-like skin disease in a murine model[J].Cell Death Dis,2018,9(8):801.
[6] Zimmermann M,Koreck A,Meyer N,et al.TNF-like weak inducer of apoptosis(TWEAK)and TNF-alpha cooperate in the induction of keratinocyte apoptosis[J].J Allergy Clin Immunol,2011,127(1):200-207.
[7] Varfolomeev E,Blankenship JW,Wayson SM,et al.IAP antagonists induce autoubiquitination of c-IAPs,NF-kappaB activation,and TNF alpha-dependent apoptosis[J].Cell,2007,131(4):669-681.
[8] Peternel S,Manestar-Blazic T,Brajac I,et al.Expression of TWEAK in normal human skin,dermatitis and epidermal neoplasms:association with proliferation and differentiation of keratinocytes[J].J Cutan Pathol,2011,38(10):780-789.
[9] Chen T,Guo ZP,Li MM,et al.Tumour necrosis factor-like weak inducer of apoptosis(TWEAK),an important mediator of endothelial inflammation,is associated with the patho-genesis of Henoch-Schonlein purpura[J].Clin Exp Immunol,2011,166(1):64-71.
[10] 杨北辰,李萌萌,邓雪琴,等.寻常型银屑病TWEAK/CD163在外周血中表达的初步研究[J].四川大学学报(医学版),2018,49(5):720-724,730.
[11] Xia L,Shen H,Xiao W,et al.Increased serum TWEAK levels in psoriatic arthritis:relationship with disease activity and matrix metalloproteinase-3 serum levels[J].Cytokine,2011,53(3):289-291.
[12] Bilgic O,Sivrikaya A,Toker A,et al.Serum levels of TWEAK in patients with psoriasis vulgaris[J].Cytokine,2016,77:10-13.
[13] Guis S,Berbis P,Stephan D,et al.TWEAK-binding autoantibodies are generated during psoriatic arthritis and are not influenced by anti-TNF therapy[J].J Transl Med,2016,14(1):185.
[14] Mysliwiec H,Mysliwiec P,Baran A,et al.Dithranol treatment of plaque-type psoriasis increases serum TNF-like weak inducer of apoptosis(TWEAK)[J].Adv Med Sci,2016,61(2):207-211.
[15] Mysliwiec H,Kiluk P,Mysliwiec P,et al.Influence of narrowband ultraviolet B phototherapy on serum tumour necrosis factor-like weak inducer of apoptosis(TWEAK)in patients with psoriasis[J].Clin Exp Dermatol,2017,42(7):786-790.
[16] Engin B,Tanakol A,Bulut H,et al.Changes in serum TNF-like weak inducer of apoptosis(TWEAK)levels and Psoriasis Area Severity Index(PASI)scores in plaque psoriasis patients treated with conventional versus anti-TNF treatments[J].Int J Dermatol,2020,59(2):207-215.
[17] Lassen UN,Meulendijks D,Siu LL,et al.A phase I monotherapy study of RG7212,a first-in-class monoclonal antibody targeting TWEAK signaling in patients with advanced cancers[J].Clin Cancer Res,2015,21(2):258-266.
[18] Zhou H,Mohamedali KA,Gonzalez-Angulo AM,et al.Development of human serine protease-based therapeutics targeting Fn14 and identification of Fn14 as a new target overexpressed in TNBC[J].Mol Cancer Ther,2014,13(11):2688-2705.